These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 16699308)

  • 1. Application of oral inorganic iodine in the treatment of Graves' disease.
    Huang Y; Xu Y; Xu M; Zhao X; Chen M
    Front Endocrinol (Lausanne); 2023; 14():1150036. PubMed ID: 37077352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiome in the Graves' disease: Comparison before and after anti-thyroid drug treatment.
    Jeong C; Baek H; Bae J; Hwang N; Ha J; Cho YS; Lim DJ
    PLoS One; 2024; 19(5):e0300678. PubMed ID: 38820506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and Management of Graves' Disease in Thailand: A Survey of Current Practice.
    Sriphrapradang C
    J Thyroid Res; 2020; 2020():8175712. PubMed ID: 32454522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of iodine nutritional status on the recurrence of hyperthyroidism and antithyroid drug efficacy in adult patients with Graves' disease: a systemic review.
    Xie Q; Zhang X; Ma J; Lu X; Zhang Y; Tong N
    Front Endocrinol (Lausanne); 2023; 14():1234918. PubMed ID: 37900151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Treatment Outcomes of Marine-Lenhart Syndrome in Japan.
    Danno H; Nishihara E; Kousaka K; Nakamura T; Kasahara T; Kudo T; Ito M; Fukata S; Nishikawa M; Miyauchi A
    Eur Thyroid J; 2021 Nov; 10(6):461-467. PubMed ID: 34950599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithyroid Drug Treatment in Graves' Disease.
    Chung JH
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):491-499. PubMed ID: 34130446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When should antithyroid drug therapy to reduce the relapse rate of hyperthyroidism in Graves' disease be discontinued?
    Park S; Song E; Oh HS; Kim M; Jeon MJ; Kim WG; Kim TY; Shong YK; Kim DM; Kim WB
    Endocrine; 2019 Aug; 65(2):348-356. PubMed ID: 31236779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidelines for the treatment of childhood-onset Graves' disease in Japan, 2016.
    ; Minamitani K; Sato H; Ohye H; Harada S; Arisaka O
    Clin Pediatr Endocrinol; 2017; 26(2):29-62. PubMed ID: 28458457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excessive iodine intake does not increase the recurrence rate of graves' disease after withdrawal of the antithyroid drug in an iodine-replete area.
    Park SM; Cho YY; Joung JY; Sohn SY; Kim SW; Chung JH
    Eur Thyroid J; 2015 Mar; 4(1):36-42. PubMed ID: 25960960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?
    Bogazzi F; Martino E; Bartalena L
    J Endocrinol Invest; 2003 Feb; 26(2):174-6. PubMed ID: 12739747
    [No Abstract]   [Full Text] [Related]  

  • 12. [Method of medical treatment for Graves' disease based on evidence based medicine].
    Nakamura H
    Nihon Rinsho; 2006 Dec; 64(12):2243-9. PubMed ID: 17154086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restriction of dietary Iodine does not ameliorate the early effect of anti-thyroid drug therapy for Graves' disease in an area of excessive iodine intake.
    Hiraiwa T; Ito M; Imagawa A; Takamatsu J; Kuma K; Miyauchi A; Hanafusa T
    J Endocrinol Invest; 2006 Apr; 29(4):380-4. PubMed ID: 16699308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal iodine supplementation during antithyroid drug therapy for Graves' disease is associated with lower recurrence rates than iodine restriction.
    Huang H; Shi Y; Liang B; Cai H; Cai Q; Lin R
    Clin Endocrinol (Oxf); 2018 Mar; 88(3):473-478. PubMed ID: 29288501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical therapy of Graves' disease: effect on remission rates of methimazole alone and in combination with triiodothyronine.
    Raber W; Kmen E; Waldhäusl W; Vierhapper H
    Eur J Endocrinol; 2000 Feb; 142(2):117-24. PubMed ID: 10664518
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.